Bionet (1784) Monthly Revenue

Market: TPEx (OTC) · Industry: Biotech & Medical · 訊聯

Bionet (1784) reported revenue of NT$94.4 million for Oct 2026, -12.0% year on year and -2.7% from the previous month. Revenue for Jan–Oct 2026 was NT$1.07 billion (+7.4% year on year).

In Oct 2026, it ranked No. 80 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$96.3 million24/10Nov 2024 NT$106.4 millionDec 2024 NT$128 millionJan 2025 NT$86.5 millionFeb 2025 NT$93.4 million25/02Mar 2025 NT$110.9 millionApr 2025 NT$102.6 millionMay 2025 NT$96.4 millionJun 2025 NT$105.4 million25/06Jul 2025 NT$112.3 millionAug 2025 NT$95.4 millionSep 2025 NT$90.3 millionOct 2025 NT$107.3 million25/10Nov 2025 NT$89.8 millionDec 2025 NT$146.4 millionJan 2026 NT$106.8 millionFeb 2026 NT$80.7 million26/02Mar 2026 NT$127.2 millionApr 2026 NT$116.5 millionMay 2026 NT$110.8 millionJun 2026 NT$111.1 million26/06Jul 2026 NT$121 millionAug 2026 NT$109.1 millionSep 2026 NT$97 millionOct 2026 NT$94.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$94.4 million-12.0%-2.7%
Sep 2026NT$97 million+7.4%-11.0%
Aug 2026NT$109.1 million+14.4%-9.9%
Jul 2026NT$121 million+7.8%+9.0%
Jun 2026NT$111.1 million+5.4%+0.2%
May 2026NT$110.8 million+15.0%-4.9%
Apr 2026NT$116.5 million+13.5%-8.4%
Mar 2026NT$127.2 million+14.7%+57.6%
Feb 2026NT$80.7 million-13.6%-24.4%
Jan 2026NT$106.8 million+23.6%-27.0%
Dec 2025NT$146.4 million+14.4%+63.1%
Nov 2025NT$89.8 million-15.7%-16.3%
Oct 2025NT$107.3 million+11.4%+18.7%
Sep 2025NT$90.3 million-0.7%-5.2%
Aug 2025NT$95.4 million-8.3%-15.1%
Jul 2025NT$112.3 million+4.8%+6.5%
Jun 2025NT$105.4 million+15.7%+9.4%
May 2025NT$96.4 million-4.2%-6.1%
Apr 2025NT$102.6 million+1.5%-7.5%
Mar 2025NT$110.9 million+4.0%+18.7%
Feb 2025NT$93.4 million+6.9%+8.1%
Jan 2025NT$86.5 million-15.6%-32.5%
Dec 2024NT$128 million+24.3%+20.3%
Nov 2024NT$106.4 million+20.6%+10.5%
Oct 2024NT$96.3 million+3.2%+5.9%

Jan–Oct 2026 cumulative: NT$1.07 billion (+7.4% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: Bionet vs PEC / Bionet vs Lotus Pharm / Bionet vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16